Is the lung important as a privileged site for the human immunodeficiency virus?
John R Clarke, David M Mitchell, Richard J Coker, Dominique Israel-Biet Opportunist lung infection, particularly Pneumocystis pneucomposition of specific point mutations in the HIV genome known to confer resistance to AZT between viruses in monia, is frequently the AIDS defining illness in HIV-1 infected individuals.
1 2 Even with the widespread use of alveolar lymphocytes, alveolar macrophages, and peripheral blood leucocytes. 17 In this respect it is tempting to prophylaxis, pulmonary disease remains a major cause of morbidity and mortality in patients with AIDS. Why the extrapolate from lymph node studies what may happen to HIV-1 in the lung following the initiation of triple lung is so important for disease in AIDS remains poorly understood. There is now evidence that HIV-1 itself may combination antiretroviral therapy. The initiation of triple combination antiretroviral therapy resulted in a marked be involved in local immunosuppression within the lung, facilitating opportunist pneumonias. However, the importreduction in detectable HIV-1 in the lymph nodes with 99.9% of virus being cleared within six months. 18 Imance of infection of alveolar leucocytes by HIV-1 remains controversial.
portantly, not all the virus was cleared and low levels of virus growth could still be detected within macrophages. Molecular techniques have shown that HIV-1 is present in the lung of some individuals early in HIV disease.
3 It is Of note, the few molecular studies that have compared HIV-1 genotypes in peripheral blood and lung have conknown that, in patients with AIDS, most have HIV-1 detectable in leucocytes from bronchoalveolar lavage centrated on comparisons between viruses in blood monocytes and alveolar macrophages. 19 One study reported (BAL).
4 5 HIV isolated from BAL fluid can usually be grown in cell cultures and is not defective.
6 7 This means genetic differences in HIV-1 virus detected in blood leucocytes compared with lung cells. 20 This finding underlines that the virus is in the lung in a form allowing replication under appropriate conditions. Analysis of the cells in BAL the potential importance of the lung in HIV-1 induced disease in view of the strong evidence that the virus is evolving fluid has shown that CD4+ alveolar lymphocytes are the predominant HIV-1 infected cells in patients with AIDS. separately and in isolation in the lung compared with the other body compartments. Mathematical modelling has estimated Alveolar macrophages have also been shown to be an important reservoir for HIV.
7-10 As HIV-1 is found prethat it may take completely inhibitory treatment with potent antiretroviral therapy for over three years to eliminate HIV dominantly in alveolar lymphocytes, it has been suggested that virus is transported to the lung within infected lymphofrom bodily compartments such as the lung.
21
Several factors control the rate at which virus is thought cytes as part of the inflammatory response to opportunist infections such as Pneumocystis carinii pneumonia.
11 It has to evolve including the speed at which the virus grows within cells which differs between alveolar lymphocytes and been shown that most HIV-1 infected individuals have a subclinical T lymphocytic alveolitis.
12 13 Of note, the prealveolar macrophages. 22 The effectiveness of the immune response is also important when considering HIV-1 indominant cell is the CD8+ T lymphocyte or cytotoxic T cell, previously thought to be responding to HIV-1 proteins fection of the lung in terms of viral load and evolution. The local immune response may be crucial in respect of expressed on the surface of alveolar macrophages.
14 However, it is now known that in some individuals CD8+ cytotoxic the effectiveness of cytotoxic T cells in limiting the growth of HIV. Factors controlling the growth of HIV in organs T cells may themselves be infected with HIV-1. 15 16 It has been suggested that these T cells become infected as a result such as the lung have to be understood before eradication strategies can be contemplated. of contact with HIV-1 budding from the surface of alveolar macrophages, providing a third cell population as a potential Quantitative studies using the polymerase chain reaction (PCR) have shown that the number of HIV-1 infected reservoir for HIV within the lung.
If HIV-1 is indeed introduced to the lung within infected lymphocytes in peripheral blood is quite small. 23 Recently it has been shown that HIV proliferates mainly in lymph lymphocytes from the blood, and this is the central mechanism whereby HIV-1 reaches the lung, several important nodes and this process is inexorable throughout the asymptomatic stages. 24 Image analysis and in situ hyissues need consideration. Firstly, HIV-1 strains isolated from the lung should be genetically identical to those bridisation studies have shown that the amount of HIV-1 on the surface of follicular dendritic cells in the lymph in peripheral blood lymphocytes obtained synchronously during inflammatory episodes. Secondly, antiretroviral nodes exceeds the levels of virus detected in peripheral blood. 25 Estimates of the half life of the virus range from drug resistant strains of HIV-1 should not be detectable in the lung before detection in the blood as a result of selective six hours to 2.5 days. 24 26 From dynamic studies it has been shown that viral turnover is extremely rapid. The relative pressure from antiretroviral agents, although they might be detectable as a result of random mutations. However, infidelity of the HIV-1 replicative enzymes, particularly the viruses reverse transcriptase, can lead to a rapid evolution of if other mechanisms operated whereby HIV-1 was transported to the lung -for example, free virus in plasmathe virus in vivo with the generation of thousands of distinct genetic variants in a short space of time. This results in HIV then the virus could evolve separately and the development of antiretroviral drug resistant strains could be established escaping immune destruction whilst gradually destroying the CD4 cell population, thus exhausting the cellular immune independent of events at other sites. Elimination of HIV-1 from infected individuals will depend on the ability of system with eventual progression to AIDS.
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HIV-1 infects relatively few alveolar lymphocytes and individual drugs to penetrate alveolar spaces and destroy HIV harboured within alveolar macrophages. This paper alveolar macrophages with a frequency of 1% and 0.1%, respectively. 28 Most of the virus in the lung appears to be focuses on studies into the uptake of drugs into alveolar macrophages. So far the only study to investigate the in a latent state in vivo as HIV-1 RNA could only be detected in a maximum of 0.002% of cells, 29 although in presence of HIV-1 antiretroviral drug resistant mutants in peripheral blood and lung found differences in the situ hybridisation probably underestimated this frequency. the lung or to serum seepage needs to be determined by In conclusion, genetic differences are observed between 
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